Global ICU-acquired Acute Kidney Treatment Market Insights and Forecast to 2028

  • Report ID:256286
  • Industry Name: Medical Care
  • Publishing Date: Jul-22
  • No. of Pages: 94
                              
ICU-acquired Acute Kidney Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global ICU-acquired Acute Kidney Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Pre-renal Intrinsic-renal Post-renal Segment by Application Public Hospital Private Hospital By Company Quark Pharmaceuticals Fresenius Medical Care B. Braun Baxter international Angion Biomedica Corp Asahi Kasei Medical By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
                        
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Pre-renal 1.2.3 Intrinsic-renal 1.2.4 Post-renal 1.3 Market by Application 1.3.1 Global ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Public Hospital 1.3.3 Private Hospital 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global ICU-acquired Acute Kidney Treatment Market Perspective (2017-2028) 2.2 ICU-acquired Acute Kidney Treatment Growth Trends by Region 2.2.1 ICU-acquired Acute Kidney Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 ICU-acquired Acute Kidney Treatment Historic Market Size by Region (2017-2022) 2.2.3 ICU-acquired Acute Kidney Treatment Forecasted Market Size by Region (2023-2028) 2.3 ICU-acquired Acute Kidney Treatment Market Dynamics 2.3.1 ICU-acquired Acute Kidney Treatment Industry Trends 2.3.2 ICU-acquired Acute Kidney Treatment Market Drivers 2.3.3 ICU-acquired Acute Kidney Treatment Market Challenges 2.3.4 ICU-acquired Acute Kidney Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top ICU-acquired Acute Kidney Treatment Players by Revenue 3.1.1 Global Top ICU-acquired Acute Kidney Treatment Players by Revenue (2017-2022) 3.1.2 Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Players (2017-2022) 3.2 Global ICU-acquired Acute Kidney Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by ICU-acquired Acute Kidney Treatment Revenue 3.4 Global ICU-acquired Acute Kidney Treatment Market Concentration Ratio 3.4.1 Global ICU-acquired Acute Kidney Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by ICU-acquired Acute Kidney Treatment Revenue in 2021 3.5 ICU-acquired Acute Kidney Treatment Key Players Head office and Area Served 3.6 Key Players ICU-acquired Acute Kidney Treatment Product Solution and Service 3.7 Date of Enter into ICU-acquired Acute Kidney Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 ICU-acquired Acute Kidney Treatment Breakdown Data by Type 4.1 Global ICU-acquired Acute Kidney Treatment Historic Market Size by Type (2017-2022) 4.2 Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Type (2023-2028) 5 ICU-acquired Acute Kidney Treatment Breakdown Data by Application 5.1 Global ICU-acquired Acute Kidney Treatment Historic Market Size by Application (2017-2022) 5.2 Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America ICU-acquired Acute Kidney Treatment Market Size (2017-2028) 6.2 North America ICU-acquired Acute Kidney Treatment Market Size by Type 6.2.1 North America ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) 6.2.2 North America ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) 6.2.3 North America ICU-acquired Acute Kidney Treatment Market Share by Type (2017-2028) 6.3 North America ICU-acquired Acute Kidney Treatment Market Size by Application 6.3.1 North America ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) 6.3.2 North America ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) 6.3.3 North America ICU-acquired Acute Kidney Treatment Market Share by Application (2017-2028) 6.4 North America ICU-acquired Acute Kidney Treatment Market Size by Country 6.4.1 North America ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) 6.4.2 North America ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe ICU-acquired Acute Kidney Treatment Market Size (2017-2028) 7.2 Europe ICU-acquired Acute Kidney Treatment Market Size by Type 7.2.1 Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) 7.2.2 Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) 7.2.3 Europe ICU-acquired Acute Kidney Treatment Market Share by Type (2017-2028) 7.3 Europe ICU-acquired Acute Kidney Treatment Market Size by Application 7.3.1 Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) 7.3.2 Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) 7.3.3 Europe ICU-acquired Acute Kidney Treatment Market Share by Application (2017-2028) 7.4 Europe ICU-acquired Acute Kidney Treatment Market Size by Country 7.4.1 Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) 7.4.2 Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size (2017-2028) 8.2 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Type 8.2.1 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) 8.2.2 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) 8.2.3 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Share by Type (2017-2028) 8.3 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Application 8.3.1 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) 8.3.2 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) 8.3.3 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Share by Application (2017-2028) 8.4 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Region 8.4.1 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2017-2022) 8.4.2 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America ICU-acquired Acute Kidney Treatment Market Size (2017-2028) 9.2 Latin America ICU-acquired Acute Kidney Treatment Market Size by Type 9.2.1 Latin America ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) 9.2.2 Latin America ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) 9.2.3 Latin America ICU-acquired Acute Kidney Treatment Market Share by Type (2017-2028) 9.3 Latin America ICU-acquired Acute Kidney Treatment Market Size by Application 9.3.1 Latin America ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) 9.3.2 Latin America ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) 9.3.3 Latin America ICU-acquired Acute Kidney Treatment Market Share by Application (2017-2028) 9.4 Latin America ICU-acquired Acute Kidney Treatment Market Size by Country 9.4.1 Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) 9.4.2 Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size (2017-2028) 10.2 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Type 10.2.1 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) 10.2.2 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) 10.2.3 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Share by Type (2017-2028) 10.3 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Application 10.3.1 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) 10.3.2 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) 10.3.3 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Share by Application (2017-2028) 10.4 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Country 10.4.1 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) 10.4.2 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Quark Pharmaceuticals 11.1.1 Quark Pharmaceuticals Company Details 11.1.2 Quark Pharmaceuticals Business Overview 11.1.3 Quark Pharmaceuticals ICU-acquired Acute Kidney Treatment Introduction 11.1.4 Quark Pharmaceuticals Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) 11.1.5 Quark Pharmaceuticals Recent Developments 11.2 Fresenius Medical Care 11.2.1 Fresenius Medical Care Company Details 11.2.2 Fresenius Medical Care Business Overview 11.2.3 Fresenius Medical Care ICU-acquired Acute Kidney Treatment Introduction 11.2.4 Fresenius Medical Care Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) 11.2.5 Fresenius Medical Care Recent Developments 11.3 B. Braun 11.3.1 B. Braun Company Details 11.3.2 B. Braun Business Overview 11.3.3 B. Braun ICU-acquired Acute Kidney Treatment Introduction 11.3.4 B. Braun Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) 11.3.5 B. Braun Recent Developments 11.4 Baxter international 11.4.1 Baxter international Company Details 11.4.2 Baxter international Business Overview 11.4.3 Baxter international ICU-acquired Acute Kidney Treatment Introduction 11.4.4 Baxter international Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) 11.4.5 Baxter international Recent Developments 11.5 Angion Biomedica Corp 11.5.1 Angion Biomedica Corp Company Details 11.5.2 Angion Biomedica Corp Business Overview 11.5.3 Angion Biomedica Corp ICU-acquired Acute Kidney Treatment Introduction 11.5.4 Angion Biomedica Corp Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) 11.5.5 Angion Biomedica Corp Recent Developments 11.6 Asahi Kasei Medical 11.6.1 Asahi Kasei Medical Company Details 11.6.2 Asahi Kasei Medical Business Overview 11.6.3 Asahi Kasei Medical ICU-acquired Acute Kidney Treatment Introduction 11.6.4 Asahi Kasei Medical Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) 11.6.5 Asahi Kasei Medical Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
                
List of Tables Table 1. Global ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Pre-renal Table 3. Key Players of Intrinsic-renal Table 4. Key Players of Post-renal Table 5. Global ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global ICU-acquired Acute Kidney Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global ICU-acquired Acute Kidney Treatment Market Size by Region (2017-2022) & (US$ Million) Table 8. Global ICU-acquired Acute Kidney Treatment Market Share by Region (2017-2022) Table 9. Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global ICU-acquired Acute Kidney Treatment Market Share by Region (2023-2028) Table 11. ICU-acquired Acute Kidney Treatment Market Trends Table 12. ICU-acquired Acute Kidney Treatment Market Drivers Table 13. ICU-acquired Acute Kidney Treatment Market Challenges Table 14. ICU-acquired Acute Kidney Treatment Market Restraints Table 15. Global ICU-acquired Acute Kidney Treatment Revenue by Players (2017-2022) & (US$ Million) Table 16. Global ICU-acquired Acute Kidney Treatment Revenue Share by Players (2017-2022) Table 17. Global Top ICU-acquired Acute Kidney Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICU-acquired Acute Kidney Treatment as of 2021) Table 18. Ranking of Global Top ICU-acquired Acute Kidney Treatment Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by ICU-acquired Acute Kidney Treatment Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players ICU-acquired Acute Kidney Treatment Product Solution and Service Table 22. Date of Enter into ICU-acquired Acute Kidney Treatment Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) & (US$ Million) Table 25. Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Type (2017-2022) Table 26. Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Type (2023-2028) Table 28. Global ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) & (US$ Million) Table 29. Global ICU-acquired Acute Kidney Treatment Revenue Share by Application (2017-2022) Table 30. Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global ICU-acquired Acute Kidney Treatment Revenue Share by Application (2023-2028) Table 32. North America ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) & (US$ Million) Table 33. North America ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) & (US$ Million) Table 34. North America ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) & (US$ Million) Table 35. North America ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) & (US$ Million) Table 36. North America ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) & (US$ Million) Table 37. North America ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) & (US$ Million) Table 38. Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) & (US$ Million) Table 39. Europe ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) & (US$ Million) Table 40. Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) & (US$ Million) Table 41. Europe ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) & (US$ Million) Table 42. Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) & (US$ Million) Table 43. Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) & (US$ Million) Table 44. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) & (US$ Million) Table 45. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) & (US$ Million) Table 46. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) & (US$ Million) Table 47. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) & (US$ Million) Table 48. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2017-2022) & (US$ Million) Table 49. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2023-2028) & (US$ Million) Table 50. Latin America ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) & (US$ Million) Table 51. Latin America ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) & (US$ Million) Table 52. Latin America ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) & (US$ Million) Table 53. Latin America ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) & (US$ Million) Table 54. Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) & (US$ Million) Table 55. Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) & (US$ Million) Table 56. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2023-2028) & (US$ Million) Table 62. Quark Pharmaceuticals Company Details Table 63. Quark Pharmaceuticals Business Overview Table 64. Quark Pharmaceuticals ICU-acquired Acute Kidney Treatment Product Table 65. Quark Pharmaceuticals Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) & (US$ Million) Table 66. Quark Pharmaceuticals Recent Developments Table 67. Fresenius Medical Care Company Details Table 68. Fresenius Medical Care Business Overview Table 69. Fresenius Medical Care ICU-acquired Acute Kidney Treatment Product Table 70. Fresenius Medical Care Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) & (US$ Million) Table 71. Fresenius Medical Care Recent Developments Table 72. B. Braun Company Details Table 73. B. Braun Business Overview Table 74. B. Braun ICU-acquired Acute Kidney Treatment Product Table 75. B. Braun Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) & (US$ Million) Table 76. B. Braun Recent Developments Table 77. Baxter international Company Details Table 78. Baxter international Business Overview Table 79. Baxter international ICU-acquired Acute Kidney Treatment Product Table 80. Baxter international Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) & (US$ Million) Table 81. Baxter international Recent Developments Table 82. Angion Biomedica Corp Company Details Table 83. Angion Biomedica Corp Business Overview Table 84. Angion Biomedica Corp ICU-acquired Acute Kidney Treatment Product Table 85. Angion Biomedica Corp Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) & (US$ Million) Table 86. Angion Biomedica Corp Recent Developments Table 87. Asahi Kasei Medical Company Details Table 88. Asahi Kasei Medical Business Overview Table 89. Asahi Kasei Medical ICU-acquired Acute Kidney Treatment Product Table 90. Asahi Kasei Medical Revenue in ICU-acquired Acute Kidney Treatment Business (2017-2022) & (US$ Million) Table 91. Asahi Kasei Medical Recent Developments Table 92. Research Programs/Design for This Report Table 93. Key Data Information from Secondary Sources Table 94. Key Data Information from Primary Sources List of Figures Figure 1. Global ICU-acquired Acute Kidney Treatment Market Share by Type: 2021 VS 2028 Figure 2. Pre-renal Features Figure 3. Intrinsic-renal Features Figure 4. Post-renal Features Figure 5. Global ICU-acquired Acute Kidney Treatment Market Share by Application: 2021 VS 2028 Figure 6. Public Hospital Case Studies Figure 7. Private Hospital Case Studies Figure 8. ICU-acquired Acute Kidney Treatment Report Years Considered Figure 9. Global ICU-acquired Acute Kidney Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global ICU-acquired Acute Kidney Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global ICU-acquired Acute Kidney Treatment Market Share by Region: 2021 VS 2028 Figure 12. Global ICU-acquired Acute Kidney Treatment Market Share by Players in 2021 Figure 13. Global Top ICU-acquired Acute Kidney Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICU-acquired Acute Kidney Treatment as of 2021) Figure 14. The Top 10 and 5 Players Market Share by ICU-acquired Acute Kidney Treatment Revenue in 2021 Figure 15. North America ICU-acquired Acute Kidney Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 16. North America ICU-acquired Acute Kidney Treatment Market Size Market Share by Type (2017-2028) Figure 17. North America ICU-acquired Acute Kidney Treatment Market Size Market Share by Application (2017-2028) Figure 18. North America ICU-acquired Acute Kidney Treatment Market Size Share by Country (2017-2028) Figure 19. United States ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe ICU-acquired Acute Kidney Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 22. Europe ICU-acquired Acute Kidney Treatment Market Size Market Share by Type (2017-2028) Figure 23. Europe ICU-acquired Acute Kidney Treatment Market Size Market Share by Application (2017-2028) Figure 24. Europe ICU-acquired Acute Kidney Treatment Market Size Share by Country (2017-2028) Figure 25. Germany ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. France ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. U.K. ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Italy ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Russia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Nordic Countries ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 32. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size Market Share by Type (2017-2028) Figure 33. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size Market Share by Application (2017-2028) Figure 34. Asia Pacific ICU-acquired Acute Kidney Treatment Market Size Share by Region (2017-2028) Figure 35. China ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Japan ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. South Korea ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Southeast Asia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. India ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Australia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 41. Latin America ICU-acquired Acute Kidney Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 42. Latin America ICU-acquired Acute Kidney Treatment Market Size Market Share by Type (2017-2028) Figure 43. Latin America ICU-acquired Acute Kidney Treatment Market Size Market Share by Application (2017-2028) Figure 44. Latin America ICU-acquired Acute Kidney Treatment Market Size Share by Country (2017-2028) Figure 45. Mexico ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Brazil ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 48. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size Market Share by Type (2017-2028) Figure 49. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size Market Share by Application (2017-2028) Figure 50. Middle East and Africa ICU-acquired Acute Kidney Treatment Market Size Share by Country (2017-2028) Figure 51. Turkey ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. Saudi Arabia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. UAE ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Quark Pharmaceuticals Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2017-2022) Figure 55. Fresenius Medical Care Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2017-2022) Figure 56. B. Braun Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2017-2022) Figure 57. Baxter international Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2017-2022) Figure 58. Angion Biomedica Corp Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2017-2022) Figure 59. Asahi Kasei Medical Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2017-2022) Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.